Related references
Note: Only part of the references are listed.A review of small molecules and drug delivery applications using gold and iron nanoparticles
Hossein Jahangirian et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen et al.
NATURE BIOTECHNOLOGY (2019)
Nusinersen in later-onset spinalmuscular atrophy Long-term results from the phase 1/2 studies
Basil T. Darras et al.
NEUROLOGY (2019)
Axonal transport and neurological disease
James N. Sleigh et al.
NATURE REVIEWS NEUROLOGY (2019)
Therapeutic Oligonucleotides: State of the Art
C. I. Edvard Smith et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction
Vladimir V. Senatorov et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
TGF- Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
Marcus A. Alvarez et al.
JOURNAL OF GASTROINTESTINAL CANCER (2019)
Antisense oligonucleotides
Daniel R. Scoles et al.
NEUROLOGY-GENETICS (2019)
Locked nucleic acid: modality, diversity, and drug discovery
Peter H. Hagedorn et al.
DRUG DISCOVERY TODAY (2018)
TGF-β Inhibition and Immunotherapy: Checkmate
Karuna Ganesh et al.
IMMUNITY (2018)
Targeting TGF-β signaling for the treatment of fibrosis
Andrea Hermina Gyoerfi et al.
MATRIX BIOLOGY (2018)
Role of proteoglycans in neuro-inflammation and central nervous system fibrosis
Femke Heindryckx et al.
MATRIX BIOLOGY (2018)
Oligonucleotide therapeutics in neurodegenerative diseases
Daniel R. Scoles et al.
RNA BIOLOGY (2018)
Transforming growth factor-1 (TGF-1) induces mouse precartilaginous stem cell differentiation through TGFRII-CK1ε--catenin signalling
Wang Qiong et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2018)
TGF-beta Signaling in Lung Health and Disease
Akira Saito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
The role of TGF-β superfamily signaling in neurological disorders
Risa Kashima et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
Transforming growth factor-β in stem cells and tissue homeostasis
Xin Xu et al.
BONE RESEARCH (2018)
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
Matthew J. A. Wood et al.
HUMAN MOLECULAR GENETICS (2017)
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke et al.
NATURE BIOTECHNOLOGY (2017)
Targeting TGF-β Signaling for Therapeutic Gain
Rosemary J. Akhurst
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Transforming growth factor-: A therapeutic target for cancer
Sulsal Haque et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
The TgF-β system as a Potential Pathogenic Player in Disease Modulation of amyotrophic lateral sclerosis
Sebastian Peters et al.
FRONTIERS IN NEUROLOGY (2017)
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
Claudia A. Chiriboga et al.
NEUROLOGY (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Antisense oligonucleotides in therapy for neurodegenerative disorders
Melvin M. Evers et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Boris Hinz
MATRIX BIOLOGY (2015)
Astrocytic TGF-β1: detrimental factor in ALS
Fumito Endo et al.
ONCOTARGET (2015)
TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons
Mahesh Kandasamy et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl-Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates
Frank Rigo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA
Sarah L. DeVos et al.
NEUROTHERAPEUTICS (2013)
Connective Tissue Growth Factor Causes Glaucoma by Modifying the Actin Cytoskeleton of the Trabecular Meshwork
Benjamin Junglas et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Dynamics of TGF-β/Smad signaling
Zhike Zi et al.
FEBS LETTERS (2012)
Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
Andrew P. Hinck
FEBS LETTERS (2012)
TGF-β control of stem cell differentiation genes
Joan Massague et al.
FEBS LETTERS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Regulation of TGF-β receptor activity
Fei Huang et al.
CELL AND BIOSCIENCE (2012)
Pirfenidone treatment of idiopathic pulmonary fibrosis
Arata Azuma
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
M. Petersen et al.
KIDNEY INTERNATIONAL (2008)
TGF-beta in neural stem cells and in tumors of the central nervous system
Ludwig Aigner et al.
CELL AND TISSUE RESEARCH (2008)
Transforming growth factor-β1 is a negative modulator of adult neurogenesis
Frank-Peter Wachs et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter
VJ Tom et al.
JOURNAL OF NEUROSCIENCE (2004)
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
BW Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Antisense technologies - Improvement through novel chemical modifications
J Kurreck
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
DA Braasch et al.
CHEMISTRY & BIOLOGY (2001)
Share Paper
